3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase NA
3
Phase 1/2
2
Phase 1
2
Phase 4
1
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
60
Neoplasms
24
Prostatic Neoplasms
21
Multiple Myeloma
18
Carcinoma, Non-Small-Cell Lung
15
Carcinoma, Hepatocellular
15
Stomach Neoplasms
11
Papillomavirus Infections
11
Lung Neoplasms
11
Colorectal Neoplasms
11
Melanoma
9
Pain, Postoperative
7
Neoplasm Metastasis
7
Leukemia, Myeloid, Acute
7
Waldenstrom Macroglobulinemia
6
Lymphoma, Non-Hodgkin
6
Leiomyoma
6
Hematologic Neoplasms
6
Brain Neoplasms
6
Thyroid Neoplasms
5
Smoking Cessation
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Polycystic Ovary Syndrome
5
Pain
5
Lymphoma
5
Glioma
5
Carcinoma, Renal Cell
5
Venous Thromboembolism
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cytokine Release Syndrome
×
1 year
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled